Lyra Therapeutics, Inc.
LYRADelisted Apr 20, 2026- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001327273
Lyra Therapeutics, Inc. was delisted on Apr 20, 2026; its insiders filed their last Form 4 on May 15, 2026; 23 institutions reported holding it in 13F filings for Q4 2025, worth $747.3K in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Lyra Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −9 vs. Q2 2021
- Shares held
- 6.67M
- −313.2K (−4.5%) vs. Q2 2021
- Total value
- $60.8M
- +$4.80M (+8.6%) vs. Q2 2021
- New holders
- 3
- 7 more added
- Sold out
- 12
- 16 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LYRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $51.1K |
| Q4 2025 | 23 | $747.3K |
| Q3 2025 | 26 | $2.93M |
| Q2 2025 | 30 | $4.42M |
| Q1 2025 | 57 | $3.23M |
| Q4 2024 | 54 | $5.54M |
| Q3 2024 | 62 | $8.36M |
| Q2 2024 | 51 | $9.06M |
| Q1 2024 | 79 | $283.4M |
| Q4 2023 | 60 | $222.0M |
| Q3 2023 | 45 | $124.8M |
| Q2 2023 | 39 | $138.4M |
| Q1 2023 | 31 | $38.1M |
| Q4 2022 | 37 | $59.9M |
| Q3 2022 | 38 | $96.0M |
| Q2 2022 | 38 | $108.9M |
| Q1 2022 | 28 | $20.2M |
| Q4 2021 | 34 | $22.4M |
| Q3 2021 | 37 | $60.8M |
| Q2 2021 | 46 | $56.0M |
| Q1 2021 | 50 | $87.6M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Lyra Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 3,222,560 | $29.4M | 0.43% | 00.0% | Unchanged |
| Polaris Venture Management Co. V, L.L.C. | 1,100,852 | $10.0M | 71.28% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 533,417 | $4.87M | 0.37% | −9,227−1.7% | Reduced |
| Ikarian Capital, LLC | 403,450 | $3.69M | 0.84% | −221,234−35.4% | Reduced |
| Vanguard Group Inc | 220,029 | $2.01M | 0.00% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 215,576 | $1.97M | 0.31% | +32,500+17.8% | Added |
| ArrowMark Colorado Holdings LLC | 139,187 | $1.27M | 0.01% | 00.0% | Unchanged |
| Parian Global Management LP | 121,300 | $1.11M | 0.79% | +121,300 | New |
| Millennium Management LLC | 118,158 | $1.08M | 0.00% | −36,977−23.8% | Reduced |
| Bank of America Corp | 110,511 | $1.01M | 0.00% | +79,524+256.6% | Added |
| Deutsche Bank AG | 76,352 | $697.0K | 0.00% | −89−0.1% | Reduced |
| Bridgeway Capital Management, LLC | 68,900 | $630.0K | 0.01% | +27,000+64.4% | Added |
| Two Sigma Advisers, LP | 58,000 | $529.0K | 0.00% | +14,000+31.8% | Added |
| Boothbay Fund Management, LLC | 39,200 | $358.0K | 0.01% | −43,955−52.9% | Reduced |
| Ensign Peak Advisors, Inc | 39,167 | $358.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 36,018 | $329.0K | 0.00% | −84−0.2% | Reduced |
| Pentwater Capital Management LP | 32,014 | $292.0K | 0.00% | +8,214+34.5% | Added |
| Morgan Stanley | 30,163 | $275.0K | 0.00% | −55,248−64.7% | Reduced |
| BlackRock Inc. | 17,818 | $163.0K | 0.00% | −2,302−11.4% | Reduced |
| Ergoteles LLC | 16,273 | $149.0K | 0.01% | −14,727−47.5% | Reduced |
| Susquehanna International Group, LLP | 15,895 | $145.0K | 0.00% | −5,634−26.2% | Reduced |
| Two Sigma Investments, LP | 13,384 | $122.0K | 0.00% | −10,500−44.0% | Reduced |
| Marshall Wace, LLP | 12,457 | $114.0K | 0.00% | −6,864−35.5% | Reduced |
| Trexquant Investment LP | 11,085 | $101.0K | 0.01% | −525−4.5% | Reduced |
| Close Asset Management Ltd | 7,000 | $64.0K | 0.00% | +7,000 | New |
| Tower Research Capital LLC (TRC) | 4,235 | $38.0K | 0.00% | +2,838+203.1% | Added |
| Advisor Group Holdings, Inc. | 1,234 | $12.0K | 0.00% | −3,200−72.2% | Reduced |
| Cardinal Capital Management, Inc. | 650 | $6.00K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 500 | $5.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 537 | $5.00K | 0.00% | +14+2.7% | Added |
| Laurel Wealth Advisors LLC | 500 | $5.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 287 | $3.00K | 0.00% | −109−27.5% | Reduced |
| Harbour Investments, Inc. | 175 | $2.00K | 0.00% | 00.0% | Unchanged |
| Koshinski Asset Management, Inc. | 200 | $1.82K | 0.00% | +200 | New |
| UBS Group AG | 18 | $0 | 0.00% | −549−96.8% | Reduced |
| JPMorgan Chase & Co | 34 | $0 | 0.00% | 00.0% | Unchanged |
| Investors Research Corp | 15 | $0 | 0.00% | 00.0% | Unchanged |
| Blair William & Co | 0 | $0 | 0.00% | −55,000−100.0% | Sold out |
| Tibra Equities Europe Ltd | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −31,539−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −19,381−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −19,093−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −18,602−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,751−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −62−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Toth Financial Advisory Corp | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |